Phillip Pang
2021
In 2021, Phillip Pang earned a total compensation of $6.4M as Chief Medical Officer at Vir Biotechnology.
Compensation breakdown
| Non-Equity Incentive Plan | $276,864 |
|---|---|
| Option Awards | $3,496,896 |
| Salary | $492,000 |
| Stock Awards | $2,156,160 |
| Other | $11,600 |
| Total | $6,433,520 |
Pang received $3.5M in option awards, accounting for 54% of the total pay in 2021.
Pang also received $276.9K in non-equity incentive plan, $492K in salary, $2.2M in stock awards and $11.6K in other compensation.
Rankings
In 2021, Phillip Pang's compensation ranked 1,978th out of 12,415 executives tracked by ExecPay. In other words, Pang earned more than 84.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,978 out of 12,415 | 84th |
Division Manufacturing | 749 out of 5,505 | 86th |
Major group Chemicals And Allied Products | 289 out of 2,375 | 88th |
Industry group Drugs | 248 out of 2,096 | 88th |
Industry Biological Products, Except Diagnostic Substances | 76 out of 449 | 83rd |
Source: SEC filing on April 7, 2022.
Pang's colleagues
We found four more compensation records of executives who worked with Phillip Pang at Vir Biotechnology in 2021.